An appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis

CAB Nieva, AG Cid, AI Romero, MF García-Bustos… - Acta Tropica, 2021 - Elsevier
Abstract Leishmaniasis is a Neglected Tropical Diseases caused by protozoan parasites of
the genus Leishmania. It is a major health problem in many tropical and subtropical regions …

New developments in the treatment of cutaneous leishmaniasis

R Dinc - Asian Pacific Journal of Tropical Medicine, 2022 - journals.lww.com
Leishmaniasis, including the cutaneous form, poses an important public health threat
around the world, while no vaccine is currently available against any form of leishmaniasis …

Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century

PF Moskowitz, AK Kurban - Clinics in dermatology, 1999 - cidjournal.com
Treatment of cutaneous leishmaniasis (CL) has witnessed a wide range of therapeutic
options over the years. Articles discussing treatment of leishmaniasis are numerous in the …

Therapeutic modalities to combat leishmaniasis, a review

H Iqbal, M Ishfaq, A Wahab, MN Abbas, I Ahmad… - Asian Pacific Journal of …, 2016 - Elsevier
Leishmaniasis is an emerging dermal disorder that causes high morbidity and mortality
levels with a wide spectrum of clinical complications. Current situation of chemotherapeutic …

Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management

M Ameen - Expert Opinion on Pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: Cutaneous leishmaniasis (CL) is a major tropical skin disease. Its
incidence continues to increase, and disease control and management are challenging …

Treatment of cutaneous leishmaniasis and insights into species-specific responses: a narrative review

RK Madusanka, H Silva, ND Karunaweera - Infectious diseases and …, 2022 - Springer
Cutaneous leishmaniasis (CL) is a complex skin infection that has imposed a heavy burden
on many developing countries and is caused by more than 20 Leishmania species. This …

Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review

M Azim, SA Khan, S Ullah, S Ullah… - PLoS neglected tropical …, 2021 - journals.plos.org
Cutaneous leishmaniasis has been endemic since decades. Millions of cases are reported
worldwide specially in developing and underdeveloped countries. There are 2 major types …

Cutaneous leishmaniasis: current and future management

NC Hepburn - Expert review of anti-infective therapy, 2003 - Taylor & Francis
Leishmaniasis remains a major world health problem that continues to increase in
incidence. This review considers epidemiology, clinical features, diagnosis and current …

Cutaneous leishmaniasis: therapeutic strategies and future directions

M Ameen - Expert opinion on pharmacotherapy, 2007 - Taylor & Francis
Cutaneous leishmaniasis is a major tropical infection caused by vector-borne protozoa of
the Leishmania species. Disease presentation, clinical course, prognosis and response to …

Drug discovery for cutaneous leishmaniasis: a review of developments in the past 15 years

HN Corman, CW McNamara, MA Bakowski - Microorganisms, 2023 - mdpi.com
Leishmaniasis is a group of vector-borne, parasitic diseases caused by over 20 species of
the protozoan Leishmania spp. The three major disease classifications, cutaneous, visceral …